Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Deferred Taxes (2019 - 2025)

Health Catalyst's Deferred Taxes history spans 7 years, with the latest figure at $195000.0 for Q4 2025.

  • For Q4 2025, Deferred Taxes fell 67.17% year-over-year to $195000.0; the TTM value through Dec 2025 reached $81000.0, up 5.19%, while the annual FY2025 figure was $81000.0, 5.19% up from the prior year.
  • Deferred Taxes reached $195000.0 in Q4 2025 per HCAT's latest filing, up from $43000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $594000.0 in Q4 2024 to a low of -$6.8 million in Q3 2021.
  • Average Deferred Taxes over 5 years is -$574550.0, with a median of $2000.0 recorded in 2021.
  • Peak YoY movement for Deferred Taxes: tumbled 180000.0% in 2022, then soared 29600.0% in 2024.
  • A 5-year view of Deferred Taxes shows it stood at -$311000.0 in 2021, then skyrocketed by 101.29% to $4000.0 in 2022, then crashed by 50.0% to $2000.0 in 2023, then skyrocketed by 29600.0% to $594000.0 in 2024, then crashed by 67.17% to $195000.0 in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Deferred Taxes are $195000.0 (Q4 2025), $43000.0 (Q3 2025), and -$224000.0 (Q2 2025).